← All trials
NCT05876858
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 13, 2023
- Primary completion
- Sep 30, 2025
- Completion date
- Sep 30, 2026
- First posted
- May 26, 2023
- Last posted
- Aug 1, 2023
- Enrollment
- 53
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of California, DavisLead sponsor
- National Institutes of Health (NIH)Collaborator
- National Center for Complementary and Integrative Health (NCCIH)Collaborator
- University of California, DavisOverall official - principal investigator
- University of California, DavisReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.